ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

9.93

-0.04 (-0.40%)

At close: Dec 5, 2025, 4:00 PM EST

9.62

-0.31 (-3.12%)

After-hours: Dec 5, 2025, 5:01 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Needle-free Intranasal	30.00K	Log In
Needle-free Intranasal Growth	-97.72%	Log In

Revenue by Geography

Fiscal year is January - December.